Scopia Capital Management LP
- SEC CIK
- 0001279150
- Latest filing
- Oct 5, 2026
INDV holding history
Indivior Pharmaceuticals, Inc. in every 13F filed by Scopia Capital Management LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
INDV overviewAll 13F holders of INDVFull Q3 2026 holdings
- Shares (Q3 2025)
- 0
- Sold out in Q3 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 9
- Since Q2 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2025 | 0 | $0 | 0.0% | −1,654,855−100.0% | Sold out | Holders |
| Q2 2025 | 1,654,855 | $24.4M | 3.0% | −220,253−11.7% | Reduced | Holders |
| Q1 2025 | 1,875,108 | $17.9M | 2.6% | +391,984+26.4% | Added | Holders |
| Q4 2024 | 1,483,124 | $18.4M | 2.0% | +199,038+15.5% | Added | Holders |
| Q3 2024 | 1,284,086 | $12.5M | 2.6% | −4,617,156−78.2% | Reduced | Holders |
| Q2 2024 | 5,901,242 | $92.5M | 13.7% | −123,991−2.1% | Reduced | Holders |
| Q1 2024 | 6,025,233 | $129.1M | 16.5% | −2,236,356−27.1% | Reduced | Holders |
| Q4 2023 | 8,261,589 | $126.2M | 16.9% | −49,778−0.6% | Reduced | Holders |
| Q3 2023 | 8,311,367 | $191.7M | 25.1% | −1,279,554−13.3% | Reduced | Holders |
| Q2 2023 | 9,590,921 | $228.3M | 24.1% | +9,590,921 | New | Holders |